NeuroOne Medical Technologies Corporation — Quarterly Financial Statistics (NASDAQ:NMTC) | MetaTrader

Open full chart

Financials

Overview Отчетность Statistics Dividends

Quarterly Annual

Cash from operating activities -2.36 M-2.67 M208.05 K-56.14 K-1.46 M-1.53 M-3.12 M -6.16 M Cash from investing activities -14.8 K-36.91 K-24.42 K-3 171-43.55 K-10.61 K-40.75 K -98.08 K Cash from financing activities 1.56 M2.54 M-509.32 K245.22 K8.23 M66.98 K147.82 K 8.69 M Free cash flow -2.38 M-2.7 M208.05 K-56.14 K-1.46 M-1.53 M-3.16 M -6.2 M

Новости

Best Momentum Stocks to Buy for January 6th

New Strong Buy Stocks for January 6th

NeuroOne назначает Джейсона Миллса из Penumbra в совет директоров

NeuroOne appoints Penumbra executive Jason Mills to board

Neuroone Medical: доходы, прибыль побили прогнозы в Q1

Neuroone Medical earnings beat, revenue topped estimates

NeuroOne: выручка за 4 кв. 2025 г. выросла, акции растут

Earnings call transcript: NeuroOne Q4 2025 sees revenue surge, stock rises

NeuroOne Medical Technologies получила отсрочку от Nasdaq

NeuroOne Medical Technologies receives Nasdaq extension to regain minimum bid price compliance

NeuroOne получила 180-дневное продление для соответствия требованиям NASDAQ

NeuroOne receives 180-day extension to regain nasdaq compliance